For the first time in a generation, licensed cannabis operators may actually have capital to deploy strategically - not just to service debt or absorb tax bills. The April 2026 Department of Justice rescheduling order, limited as it is in scope, opens a genuine window for state-licensed medical cannabis businesses to escape the punishing math of Section 280E. What they do with that recovered margin will define the next phase of the industry's maturation. One option that deserves serious attention: captive insurance.
The 280E Problem, in Plain Terms
Section 280E has functioned as a structural tax on legal compliance. Because it prohibits businesses trafficking in Schedule I or II controlled substances from deducting ordinary business expenses - rent, payroll, marketing, general and administrative costs - cannabis operators have faced effective federal tax rates that bear no resemblance to any other licensed retail sector. Operators may deduct cost of goods sold under §471, and nothing else. Among the largest publicly traded multi-state operators, contested 280E tax liability now exceeds $1.7 billion collectively. That is not a rounding error. That is capital that never reached balance sheets, never funded infrastructure, never addressed risk.
The April 2026 order changes the calculus for qualifying operators - specifically, those holding state-issued medical licenses. The IRS has issued no formal guidance, and the DEA rulemaking process is ongoing, with a hearing scheduled for late June into July. But the statutory logic is clear enough that operators and their counsel are already moving. The window to apply through the DEA Diversion portal for expedited registration review closes June 26, 2026. That is a near-term operational deadline, not a theoretical one.
Risk Has Always Been the Hidden Liability
Here's the thing that 280E obscured: cannabis operators were always carrying enormous unaddressed risk. Product recall exposure, business interruption vulnerability, liability gaps in commercial coverage - these weren't theoretical problems. They were deferred ones. With effective tax rates consuming the margin that might otherwise fund proper risk management, most operators made do with whatever commercial cannabis insurance the market would offer, which has historically been expensive, narrow in scope, and structured by underwriters with limited appetite for the asset class.
Commercial cannabis policies routinely exclude or severely limit coverage for regulatory actions, license suspension, product contamination events without a government-mandated recall trigger, and loss of business income tied to compliance failures. The operator pays the premium. The capital leaves. The coverage gaps remain. That's a cost center that generates no return and provides incomplete protection.
What a Captive Actually Does
A captive insurance company is a licensed insurer owned and controlled by the business it insures. Instead of transferring premium dollars to a third-party commercial carrier, the operator capitalizes its own insurance entity - purpose-built to cover the specific risks its commercial policies miss or underprice. The captive collects premiums from the operating entities, builds reserves, and pays claims. The underwriting profit and investment income stay inside the structure.
In a well-run captive, that capital is not gone. It is working. Reserves held in the captive accumulate over time. If losses are lower than projected - which disciplined operators with strong compliance infrastructure tend to produce - the retained earnings remain within the owner's enterprise. The risk spend converts from a sunk cost into a balance sheet asset. That's a structural shift, not a cosmetic one.
For cannabis operators specifically, captives can be designed to address coverage categories that commercial markets handle poorly: regulatory defense costs, license protection, product contamination and recall beyond what a standard product liability policy covers, and business interruption tied to state enforcement actions rather than physical damage. These are real exposures. Any operator who has watched a competitor face a METRC discrepancy, a failed COA, or a state-mandated inventory hold understands what business interruption looks like in this industry. It rarely looks like a fire.
The Strategic Moment, and Its Limits
The opportunity is specific. State-licensed medical operators who qualify under the April 2026 order - and who move quickly through the registration and tax planning process with qualified legal and tax counsel - may find themselves with meaningful after-tax capital for the first time. For some, that capital will go toward debt service or expansion. For others, it will fund M&A. A captive structure deserves a seat at that table, particularly for multi-state operators with diversified risk profiles complex enough to benefit from a consolidated, owned insurance vehicle.
A few cautions are worth stating plainly. Captives require proper capitalization, domicile licensing, actuarial support, and rigorous claims handling to withstand IRS scrutiny - and the IRS has been aggressive in examining captive arrangements used improperly as tax shelters. The structure must be designed around genuine insurance need, not tax optimization theater. Cannabis operators considering this path need counsel experienced in both captive insurance formation and the specific regulatory posture of the cannabis sector. The 280E thaw created the capital. The captive structure provides a disciplined way to deploy it. Neither element works without the other - and neither works without serious professional guidance.
Adult-use operators remain outside the scope of the April order for now, pending the outcome of DEA rulemaking. The regulatory environment is unsettled. Banking access remains a legislative problem. The SAFER Banking Act is stalled. Those facts haven't changed. But for qualifying medical operators, the question is no longer whether capital exists to address structural risk - it's whether operators will use it strategically or let it dissolve back into the same operational pressures that consumed every prior margin improvement. A captive won't fix 280E. 280E relief might, finally, make a captive possible.
